The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Nonalcoholic Steatohepatitis with Metabolic Syndrome

대사증후군을 동반한 비알코올성 지방간염 치험 1례

  • Kim, Ha-yeon (Dept. of Internal Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Joo, Seong-hee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Bae, Jung-han (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jang, Eun-gyeong (Dept. of Internal Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Young-chul (Dept. of Internal Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Jang-hoon (Dept. of Internal Medicine, College of Korean Medicine, Kyung Hee University)
  • 김하연 (경희대학교 한의과대학 간계내과학교실) ;
  • 주성희 (경희대학교 대학원 임상한의학과) ;
  • 배정한 (경희대학교 대학원 임상한의학과) ;
  • 장은경 (경희대학교 한의과대학 간계내과학교실) ;
  • 김영철 (경희대학교 한의과대학 간계내과학교실) ;
  • 이장훈 (경희대학교 한의과대학 간계내과학교실)
  • Received : 2017.03.24
  • Accepted : 2017.05.25
  • Published : 2017.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this case report is to describe the efficacy of treatment with Korean medicine of a patient with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. Methods: The patient was treated with Korean medicine (Saenggangunbi-tang) from April 27, 2016 to October 22, 2016. Results: Post-treatment, the patient's AST and ALT levels were significantly decreased. Triglyceride levels were within the normal range during the treatment. Abdominal ultrasonography revealed a significant improvement in hepatic steatosis. Conclusions: The results suggest that Saenggangunbi-tang could be an effective treatment for NASH with metabolic syndrome.

Keywords

References

  1. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clinical and molecular hepatology 2013;19(4) :325-48. https://doi.org/10.3350/cmh.2013.19.4.325
  2. Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver int 2017;37(Suppl. 1) :81-4. https://doi.org/10.1111/liv.13299
  3. Leem JC, Koh EH. Management of Non-alcoholic Fatty Liver Disease. Journal of Korean Diabetes 2014:15(2):93-7. https://doi.org/10.4093/jkd.2014.15.2.93
  4. ES Choi, HY Kim, YH Cho, Jang EG, Woo HJ, Kim YC, et al. A Case Report of Adolescent Nonalcoholic Fatty Liver Disease (NAFLD) with Severe Obesity. J Int Korean Med 2015;spr:89-95.
  5. Dennis K. Harrison's Principles of Internal Medicine. New York: McGraw Hill Education Medical; 2015, p. 2049-55.
  6. Neuschwander T, Brent A. Non-alcoholic fatty liver disease. BMC medicine 2017;15(1):45. https://doi.org/10.1186/s12916-017-0806-8
  7. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000; 32(4):689-92. https://doi.org/10.1053/jhep.2000.17894
  8. Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Tokushige K, et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009;44(Suppl 19):89-95. https://doi.org/10.1007/s00535-008-2262-x
  9. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51(1):121-9. https://doi.org/10.1002/hep.23276
  10. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 2010;52(1):79-104. https://doi.org/10.1002/hep.23623
  11. Kang KR, Baek SH, Lee MS, Jung YJ, Choi AR, Shin JS. A Male Nonalcoholic Steatohepatitis (NASH) Patient Diagnosed with Moderate Fibrosis using Fibroscan-a Case Report. J Int Korean Med 2015;spr:120-6.
  12. Hong SI. The Effects of Saengkankunbi-tang and Its Composition on Free Fatty Acid-Induced Lipotoxicity in HepG2 Cell. J Int Korean Med 2013;34(1):14-30.
  13. Kim JY, Kim YC, Lee JH, Woo HJ. The Effects of Saengkankunbi-tang on Proliferation, Apoptosis and Cell Signaling Pathways of HepG2 Cells. J Int Korean Med 2006;27(1):149-65.
  14. Lee E, Kim YC, Ko H. Inhibitory Effect of Saengangeonbitang-gasamchilgn on Liver Fibrosis in Rat. J Int Korean Med 2008;29(2):500-11.
  15. Hur JI, Choi BH, Kim DW, Park K, Kim DJ, Byun JS. Case of Oriental Obesity Treatment's Effect on Improvement of Nonalcoholic Steatohepatitis Patient's Liver Function. Korean J Oriental Physiology & Pathology 2006;20(6):1785-8.
  16. Park KS, Hwang DS, Cho JH, Lee CH, Lee KS. A Case Study on a Patient with Non-alcoholic Fatty Liver Disease(NAFLD) Improved on Sonography by Oriental Obesity Therapy. Journal of Society of Korean Medicine for Obesity Research 2009;9(1):79-86.
  17. Heo JK, Hwang DS, Lee CH, Lee KS. A case study on a Non-alcoholic fatty liver disease (NAFLD) patient improved by the oriental obesity therapy program. Journal of Society of Korean Medicine for Obesity Research 2007; 7(2):85-94.